LATEST WRITING
Policy & Advocacy · October 12, 2026
My submitted FDA comment supports carefully supervised ibogaine research, with patient safety, informed consent, medication continuity, and long-term follow-up at the center.
Read the article →Mental Health & Human Experience · September 30, 2026
You can care deeply for people and still feel at the edge of their group. Exploring an emerging concept with compassion, curiosity, and respect for what research has yet to establish.
Read article →Essays & Reflections · September 27, 2026
A child's question about disappearing after trauma reveals how deeply harm can unsettle identity, belonging, and hope.
Read article →Health & Research · September 26, 2026
A careful look at fasting, cellular repair, mood, and cognition, with attention to the limits of human evidence and mental health risks.
Read article →Essays & Reflections · September 22, 2026
On the quiet acts of remembrance that can give grief a place to go.
Read article →Policy & Advocacy · September 5, 2026
My public comment proposes product-specific evaluation, supervised clinical access, provider training, and outcomes tracking for future FDA-approved psychedelic therapies.
Read article →